Close Menu

NEW YORK (GenomeWeb) – Veracyte has entered into a co-promotion agreement with Genzyme for the Afirma Gene Expression Classifier test in Brazil and Singapore, according to the firm's Form 10-K recently filed with the US Securities and Exchange Commission.

Under the terms of the agreement, Veracyte will pay Genzyme 25 percent of cash receipts from the sale of the Afirma GEC test in Brazil and Singapore over a five-year period that began on Jan. 1, 2015.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers tie a variant in ADAMTS3 to breathing difficulties in dissimilar dog breeds, according to Discover's D-brief blog.

Parents of children with rare genetic disease have to contend with shifts in the interpretation of genetic variants, the Wall Street Journal reports.

The Japan Times reports that researchers sequenced the genome of a woman who lived during the Jomon period.

In Science this week: single-nucleus RNA sequencing of brain tissue from individuals with autism, and more.